. Author manuscript; available in PMC: 2021 Jan 1.

Published in final edited form as: Respir Med. 2019 Nov 20;161:105822. doi: 10.1016/j.rmed.2019.105822

Table 2.

Clinical characteristics of sarcoidosis subjects at their initial visit

Imaging: Scadding Stage			N (%)

0			11^{^†} (10)

1			13 (12)

2			50 (46)

3			10 (9)

4			24 (22)

Immunosuppression use			49 (45)

Extra-thoracic involvement			74 (69)

Pulmonary Function Tests
	N	Mean (SD)	Range

FVC %predicted	100	96 (15)	59 - 140

FEV1 %predicted	100	90 (18)	28 - 140

FEV1/FVC	100	0.75 (0.088)	0.34-0.95

DLCO %predicted	73	71 (14)	39 - 108

TLC %predicted	68	96 (15)	59 - 131

^†

Two subjects with Scadding stage 0 had prior lung involvement, the other subjects either had neurologic or skin involvement

Abbreviations: DLCO = Diffusing Capacity of the Lungs for Carbon Monoxide, FEV1 = Forced Expiratory Volume in 1 Second, FEV1/FVC = Forced Expiratory Volume in 1 Second to Forced Vital Capacity ratio, FVC = Forced Vital Capacity, TLC = Total Lung Capacity